1. Home
  2. LRMR vs LPA Comparison

LRMR vs LPA Comparison

Compare LRMR & LPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • LPA
  • Stock Information
  • Founded
  • LRMR N/A
  • LPA 2013
  • Country
  • LRMR United States
  • LPA United States
  • Employees
  • LRMR N/A
  • LPA N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • LPA
  • Sector
  • LRMR Health Care
  • LPA
  • Exchange
  • LRMR Nasdaq
  • LPA Nasdaq
  • Market Cap
  • LRMR 204.9M
  • LPA 196.1M
  • IPO Year
  • LRMR N/A
  • LPA N/A
  • Fundamental
  • Price
  • LRMR $4.01
  • LPA $6.10
  • Analyst Decision
  • LRMR Strong Buy
  • LPA
  • Analyst Count
  • LRMR 8
  • LPA 0
  • Target Price
  • LRMR $17.88
  • LPA N/A
  • AVG Volume (30 Days)
  • LRMR 1.8M
  • LPA 14.8K
  • Earning Date
  • LRMR 08-14-2025
  • LPA 08-13-2025
  • Dividend Yield
  • LRMR N/A
  • LPA N/A
  • EPS Growth
  • LRMR N/A
  • LPA N/A
  • EPS
  • LRMR N/A
  • LPA 0.57
  • Revenue
  • LRMR N/A
  • LPA $45,218,701.00
  • Revenue This Year
  • LRMR N/A
  • LPA N/A
  • Revenue Next Year
  • LRMR N/A
  • LPA N/A
  • P/E Ratio
  • LRMR N/A
  • LPA $10.78
  • Revenue Growth
  • LRMR N/A
  • LPA 7.03
  • 52 Week Low
  • LRMR $1.61
  • LPA $5.85
  • 52 Week High
  • LRMR $9.50
  • LPA $15.85
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 60.80
  • LPA N/A
  • Support Level
  • LRMR $3.42
  • LPA N/A
  • Resistance Level
  • LRMR $3.97
  • LPA N/A
  • Average True Range (ATR)
  • LRMR 0.38
  • LPA 0.00
  • MACD
  • LRMR 0.02
  • LPA 0.00
  • Stochastic Oscillator
  • LRMR 67.61
  • LPA 0.00

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

Share on Social Networks: